• According to Transparency Market Research’s latest report on the global Fetal Bovine Serum Market for the historical period 2017–2018 and forecast period 2019–2027, Increased demand for fetal bovine serum in the growing pharmaceutical & biotechnology industry, Increase in academic research worldwide and Rising consumption of fetal bovine serum in emerging markets are the factors projected to drive the global Fetal Bovine Serum Market during the forecast period.
  • According to the report, the global Fetal Bovine Serum Market was valued at US$ 0.9 Bn in 2018 and is anticipated to expand at a CAGR of 5.8% from 2019 to 2027 
new global fa fetal bovine serum market

To know the scope of our report Get a Sample on Fetal Bovine Serum Market

Increased demand for fetal bovine serum in the growing pharmaceutical & biotechnology industry: Key Drivers

  • The number of pharmaceutical companies is increasing across the globe. A majority of existing as well as new pharmaceutical companies are focusing more on research and development activities.
  • Funding for research projects by academic research institutes is also on the rise. Due to this, the demand for fetal bovine serum is increasing. However, suppliers are not been able to meet the demand for fetal bovine serum due to shortage of fetal bovine blood. This has led to significant increase in prices of fetal bovine serum. This price rise is expected to drive the global fetal bovine serum market in the near future.
  • The global pharmaceutical expenditure on R&D stood at US$ 157 Bn in 2016, an increase of 6.1% over the expenditure in 2015 i.e. US$ 148 Bn
  • The global research & development expenditure increased by 12.0% from US$ 40.6 Bn in 2015 to US$ 45.7 Bn in 2016
  • The research & development expenditure of biotech companies in the U.K. stood at US$ 1.2 Bn in 2013
  • Various government initiatives are supporting the research & development activities of the pharmaceutical & biotechnology industry. Hence, use of fetal bovine serum is also increasing. Similarly, production of biopharmaceutical products such as vaccines is also rising in order to meet the global demand for vaccines.

Increase in academic research worldwide Boost Market Growth

  • Fetal bovine serum is a major raw material used in biotechnology, pharmaceutical, diagnostics, and veterinary industries. Research & development activities in the academic sector heavily rely on fetal bovine serum due to its proven effectiveness and safety. Various governments are collaborating with academic research institutes for research requirements.
  • Increase in the number of academic research institutes worldwide is expected to augment the demand for fetal bovine serum during the forecast period. This is expected to drive the global fetal bovine serum market from 2019 to 2027.

Get a glimpse of the in-depth analysis through our Report Brochure

Rising consumption of fetal bovine serum in emerging markets

  • Demand for fetal bovine serum from emerging markets such as China, India, South Korea, and countries of the Middle East is increasing. China recently allowed to import fetal bovine serum from the U.S., for the first time after 2003, to fulfill the domestic demand. Demand for fetal bovine serum from South Korea has been rising continuously.
  • Statistics suggest that the consumption of fetal bovine serum imported from the U.S. by South Korea in 2015 stood at 20,000 liters, which is expected to increase in the next few years
  • The increasing number of contract research organizations in Asia, especially China and India, is driving the demand for fetal bovine serum in the region. This, in turn, is expected to drive the global fetal bovine serum market during the forecast period.

Ethical and scientific issues associated with fetal bovine serum to Hamper Market

  • Demand for fetal bovine serum from emerging markets such as China, India, South Korea, and countries of the Middle East is increasing. China allowed to import fetal bovine serum from the U.S., for the first time after 2003, to fulfill the domestic demand. Demand for fetal bovine serum from South Korea has been rising continuously.
  • Statistics suggest that the consumption of fetal bovine serum imported from the U.S. by South Korea in 2015 stood at 20,000 liters, which is expected to increase in the next few years
  • The increasing number of contract research organizations in Asia, especially China and India, is driving the demand for fetal bovine serum in the region. This, in turn, is expected to drive the global fetal bovine serum market during the forecast period.

 Global Fetal Bovine Serum Market: Competitive Landscape

  • This report profiles major players in the global Fetal Bovine Serum Market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global Fetal Bovine Serum Market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global
    • Fetal Bovine Serum Market are Merck KGa
    • GE Healthcare
    • Thermo Fisher Scientific Inc.
    • TCS Biosciences Ltd.
    • HiMedia Laboratories
    • Atlanta Biologicals, Inc.
    • PAN-Biotech
    • Rocky Mountain Biologicals
    • Bovogen Biologicals Pty Ltd.
    • Tissue Culture Biologicals

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Fetal Bovine Serum Market: Key Developments

Key players in the global Fetal Bovine Serum Market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global Fetal Bovine Serum Market. A few expansion strategies adopted by players operating in the global Fetal Bovine Serum Market are:

  • In November 2017, Merck announced its plan for the extension of its strategic alliance with Samsung BioLogics on biopharmaceutical manufacturing and biologics process development
  • In October, 2017, Merck announced patent issuance by the Canadian Patent Office for its application covering the company’s CRISPR technology used in a genomic-integration method
  • In October, 2017, the company announced opening of Life Science Center in Burlington, Massachusetts with focus on scientific advancement and customer collaboration
  • In September, 2017, the company announced the opening of its first BioReliance End-to-End Bio development Center in the Asia Pacific (APAC) region in China
  • In May 2017, the company launched EX-CELL Advanced HD Perfusion Medium, an industry’s first off-the-shelf cell culture media for perfusion processes
  • In January 2016, Thermo Fisher Scientific, Inc. acquired Affymetrix and incorporated the company under its Life Sciences Solutions segment
  • In May 2016, Thermo Fisher Scientific acquired FEI, a high-performance electron microscopy company. This acquisition helped Thermo Fisher Scientific strengthen its presence in the global market.
  • In July 2017, GE Healthcare and HeartFlow, Inc. entered into a global collaboration agreement to increase clinical availability and adoption of HeartFlow FFRct. The collaboration will involve computed tomography (CT) scanners from GE Healthcare with HeartFlow FFRc.
  • In May 2017, Partners HealthCare and GE Healthcare entered into a 10-year collaboration to integrate artificial intelligence into every aspect of patients’ journey

The report on the global Fetal Bovine Serum Market discussed individual strategies, followed by company profiles of manufacturers of Fetal Bovine Serum. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global Fetal Bovine Serum Market.

TMR’s report on the global Fetal Bovine Serum Market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2018 to 2027. The report provides revenue of the global Fetal Bovine Serum Market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global Fetal Bovine Serum Market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global Fetal Bovine Serum Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global Fetal Bovine Serum Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global Fetal Bovine Serum Market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global Fetal Bovine Serum Market.

The report delves into the competitive landscape of the global Fetal Bovine Serum Market. Key players operating in the global Fetal Bovine Serum Market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global Fetal Bovine Serum Market that have been profiled in this report.

Key Questions Answered in Global Fetal Bovine Serum Market Report

  • What is the scope of growth of product companies in the global Fetal Bovine Serum Market?
  • What will be the Y-o-Y growth of the global Fetal Bovine Serum Market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global Fetal Bovine Serum Market?
  • Will North America continue to be the most profitable market for oral contraceptive pills providers?
  • Which factors are anticipated to hamper the growth of the global Fetal Bovine Serum Market during the forecast period?
  • Which are the leading companies in the global Fetal Bovine Serum Market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global Fetal Bovine Serum Market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global Fetal Bovine Serum Market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the Fetal Bovine Serum Market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the Fetal Bovine Serum Market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global Fetal Bovine Serum Market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global Fetal Bovine Serum Market more reliably and accurately.

Regional Segmentation of Fetal Bovine Serum Market

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Global Fetal Bovine Serum Market – Segmentation

By Application

Drug Discovery

Cell Media Culture

In vitro Fertilization

Human and Animal Vaccine production

Diagnostics

Others

By End User

Research & Academic Institutes

Industry (pharma, biotech, etc.)

By Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Fetal Bovine Serum Market

Buy Now